Bempedoic Acid for High-Risk Primary Prevention of Cardiovascular Disease: Not a Statin Substitute but a Good Plan B

JAMA. 2023 Jul 11;330(2):123-125. doi: 10.1001/jama.2023.9854.

Author

Dhruv S Kazi^{1

2}

Affiliations

¹ Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
² Harvard Medical School, Boston, Massachusetts.

PMID: 37354548
DOI: 10.1001/jama.2023.9854

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cardiovascular Diseases* / prevention & control
Fatty Acids
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Hypolipidemic Agents* / therapeutic use
Primary Prevention

Substances

8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
Fatty Acids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents